Similar articles

• [Treatment of bronchogenic carcinoma with malignant pleural effusion (author's transl)].

  Kikuchi K, Ishihara T, Inoue H, Fukai S, Ogawa J. Kikuchi K, et al. Kyobu Geka. 1977 Jul;30(7):556-60. Kyobu Geka. 1977. PMID: 904104 Japanese. No abstract available.
• Status of lipid peroxidation and antioxidant enzymes in malignant (bronchogenic carcinoma) and non-malignant pleural effusions.

  Vanisree AJ, Shyamaladevi CS. Vanisree AJ, et al. Indian J Cancer. 1999 Jun-Dec;36(2-4):127-34. Indian J Cancer. 1999. PMID: 10921216
• [Pleural effusions of neoplastic etiology].

  Zlatanov Z, Peneva M, Kokoshian M. Zlatanov Z, et al. Vutr Boles. 1982;21(2):129-33. Vutr Boles. 1982. PMID: 7101882 Bulgarian.
• [Paraneoplastic syndromes in bronchial carcinoma (author's transl)].

  Roelandts J, Lenaerts F. Roelandts J, et al. Acta Tuberc Pneumol Belg. 1978 Jan-Mar;69(1):29-52. Acta Tuberc Pneumol Belg. 1978. PMID: 362873 Review. Dutch. No abstract available.
• [Pleurodesis with tetracycline in neoplastic effusions. Is an acid pH necessary?].

  Varela G, de Pablo P, Ruiz MJ. Varela G, et al. Rev Med Univ Navarra. 1988 Jul-Sep;32(3):143-6. Rev Med Univ Navarra. 1988. PMID: 3070685 Review. Spanish.